Advanced Search
Contact | Corporate | Help

Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma

Sponsors:
  • Novartis
  • Genentech
  • Tanox
Phases:
  • Phase IV
IndicationsAcronym:
  • Asthma
Age Groups:
  • Child
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: omalizumab
  • Other: optimized asthma therapy
Enrollment:
450

Additional information about NCT00264849.


SourceSolution © 2008-2012